Sasco Capital’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-48,150
Closed -$3.76M 50
2022
Q3
$3.76M Sell
48,150
-134,674
-74% -$10.8M 0.56% 32
2022
Q2
$12.4M Sell
182,824
-86,860
-32% -$6.06M 1.69% 32
2022
Q1
$17.7M Sell
269,684
-45,270
-14% -$2.63M 2.2% 29
2021
Q4
$19.1M Sell
314,954
-6,850
-2% -$408K 2.2% 22
2021
Q3
$20.5M Sell
321,804
-8,890
-3% -$561K 2.51% 22
2021
Q2
$20.8M Hold
330,694
2.45% 23
2021
Q1
$18.9M Sell
330,694
-12,580
-4% -$681K 2.36% 24
2020
Q4
$17.3M Hold
343,274
2.44% 21
2020
Q3
$10.1M Buy
343,274
+78,784
+30% +$2.29M 1.74% 30
2020
Q2
$6.64M Buy
+264,490
New +$6.6M 1.04% 33

Other funds holding ACHC

Sasco Capital's ACHC Position: Q4 2022 in Review

Sasco Capital sold out of Acadia Healthcare (ACHC) in Q4 2022, closing a stake of 48,150 shares — an estimated $3.76M sold.

Sasco Capital first reported a position in ACHC in Q2 2020 and held it in 10 quarters. The position peaked at $20.8M in Q2 2021. 346 funds tracked by Wall St. Rank hold ACHC as of Q4 2022.

  • Sasco Capital reported no remaining Acadia Healthcare position as of Q4 2022 after selling out during the quarter.
  • Sasco Capital sold 48,150 Acadia Healthcare shares in Q4 2022, an estimated $3.76M.
  • Sasco Capital first reported a position in Acadia Healthcare in Q2 2020 and held it in 10 quarters.
  • Sasco Capital's Acadia Healthcare position peaked at $20.8M in Q2 2021.
  • 346 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2022.

Based on Sasco Capital's 13F filing for Q4 2022, filed 10 Feb 2023.